Substituted tetrahydropyran spiro pyrrolidinone and piperidinone, preparation and therapeutic use thereof

Details for Australian Patent Application No. 2009322243 (hide)

Owner Sanofi-Aventis

Inventors Gao, Zhongli; Hartung, Ryan; Stefany, David

Agent Watermark

Pub. Number AU-A-2009322243

PCT Pub. Number WO2010/065798

Priority 0955909 28.08.09 FR; 61/120,087 05.12.08 US

Filing date 4 December 2009

Wipo publication date 10 June 2010

International Classifications

C07D 491/107 (2006.01) Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or

A61K 31/407 (2006.01) - condensed with heterocyclic ring systems, e.g. ketorolac, physostigmine

A61K 31/438 (2006.01) - the ring being spiro-condensed with carbocyclic or heterocyclic ring systems

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

Event Publications

23 June 2011 PCT application entered the National Phase

  PCT publication WO2010/065798 Priority application(s): WO2010/065798

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009322248-Substituted piperidine spiro pyrrolidinone and piperidinones used as H3 modulators

2009322238-Exhaust flow control system and method